Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.625 USD | -7.50% | 0.00% | -11.06% |
04-01 | Capstone Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Capstone Holding Corp. Announces Change in Board of Directors | CI |
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Novel Peptides and Other Molecules
100.0
%
| 67 | 100.0 % | 62 | 100.0 % | -7.84% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 67 | 100.0 % | 62 | 100.0 % | -7.84% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Toporek
CEO | Chief Executive Officer | 59 | 17-07-13 |
Edward Schultz
DFI | Director of Finance/CFO | - | - |
Matthew Lipman
BRD | Director/Board Member | 45 | 17-07-13 |
Jock Holliman
BRD | Director/Board Member | 70 | 87-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jock Holliman
BRD | Director/Board Member | 70 | 87-08-31 |
Michael Toporek
CEO | Chief Executive Officer | 59 | 17-07-13 |
Matthew Lipman
BRD | Director/Board Member | 45 | 17-07-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 157,610 | 157,610 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Capstone Therapeutics Corp.
1275 West Washington Street Suite 104
85281, Tempe
+602-286-5520
http://www.capstonethx.comSector
1st Jan change | Capi. | |
---|---|---|
-11.06% | 729K | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- CAPS Stock
- Company Capstone Holding Corp.